Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Koichi Okudera"'
Autor:
Masaki Dobashi, Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Yoshiko Ishioka, Toshihiro Shiratori, Fumihiko Okumura, Chiori Tabe, Yoshihito Tanaka, Takeshi Morimoto, Yukihiro Hasegawa, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Publikováno v:
SAGE Open Medicine, Vol 9 (2021)
Background: The INPULSIS trials revealed that nintedanib reduced the decline in lung function in patients with idiopathic pulmonary fibrosis. We aimed to evaluate the efficacy and safety of nintedanib in Japanese idiopathic pulmonary fibrosis patient
Externí odkaz:
https://doaj.org/article/757362f920d74ab8a1a0332ab2961ec5
Autor:
Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, Yoshihito Tanaka, Masamichi Itoga, Kunihiko Nakamura, Akihito Hayashi, Mika Kumagai, Hideo Yasugahira, Megumi Mikuniya, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy. Methods Patients were required to have an Eastern Cooperative Oncolog
Externí odkaz:
https://doaj.org/article/a4bd2e1304764c82beec3bc1bb27601a
Publikováno v:
Translational Lung Cancer Research. 12:719-726
Autor:
Takashi, Fukushima, Tomonori, Makiguchi, Yusuke, Tanaka, Kei, Chubachi, Mina, Ishidoya, Sachio, Suzuki, Hisashi, Tanaka, Kageaki, Taima, Yukihiro, Hasegawa, Koichi, Okudera, Sadatomo, Tasaka
Publikováno v:
Oncology letters. 24(4)
Small-cell lung cancer (SCLC) is a highly malignant tumor, and no standard third-line therapy has been established. The present study retrospectively analyzed the efficacy and safety of platinum-based regimens in patients with third-line SCLC who rec
Autor:
Kageaki Taima, Sadatomo Tasaka, Akihito Hayashi, Hideo Yasugahira, Koichi Okudera, Shingo Takanashi, Takeshi Morimoto, Yoshihito Tanaka, Kunihiko Nakamura, Masamichi Itoga, Mika Kumagai, Megumi Mikuniya, Hisashi Tanaka
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-6 (2017)
BMC Cancer
BMC Cancer
We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy. Patients were required to have an Eastern Cooperative Oncology Group performance status o
Autor:
Koichi Okudera, Hideo Yasugahira, Shingo Takanashi, Sadatomo Tasaka, Yoshiko Ishioka, Toshihiro Shiratori, Junichiro Tsuchiya, Yukihiro Hasegawa, Hisashi Tanaka, Keisuke Baba, Kageaki Taima, Hideyuki Nakagawa, Hiroaki Sakamoto, Masamichi Itoga
Publikováno v:
Medical Oncology. 36
Afatinib, a second-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) for mutant non-small cell lung cancer (NSCLC), was approved in Japan in 2014. This study evaluated clinical outcomes of afatinib in real-world pract
Autor:
Masamichi Itoga, Chiori Tabe, Yoshinori Hasegawa, Toshihiro Shiratori, Yoshihito Tanaka, Sadatomo Tasaka, Yoshiko Ishioka, Koichi Okudera, Kageaki Taima, Fumihiko Okumura, Hideo Yasugahira, M. Dobashi, Keisuke Baba, Hisashi Tanaka, Shingo Takanashi
Publikováno v:
C39. IDIOPATHIC INTERSTITIAL PNEUMONIA: THERAPY.
Autor:
Shingo Takanashi, Masamichi Itoga, Yoshiko Ishioka, Yukihiro Hasegawa, Chiori Tabe, Fumihiko Okumura, Hideo Yasugahira, Toshihiro Shiratori, Masaki Dobashi, Takeshi Morimoto, Kageaki Taima, Koichi Okudera, Sadatomo Tasaka, Hisashi Tanaka, Yoshihito Tanaka
Publikováno v:
SAGE Open Medicine, Vol 9 (2021)
SAGE Open Medicine
SAGE Open Medicine
Background: The INPULSIS trials revealed that nintedanib reduced the decline in lung function in patients with idiopathic pulmonary fibrosis. We aimed to evaluate the efficacy and safety of nintedanib in Japanese idiopathic pulmonary fibrosis patient
Autor:
Hideo Yasugahira, Takeshi Morimoto, Toshihiro Shiratori, Yoshiko Ishioka, Hiroshi Tanaka, Koichi Okudera, Yoshinori Hasegawa, Shingo Takanashi, Masamichi Itoga, Hideyuki Nakagawa, Keisuke Baba, Yoshihito Tanaka, Sadatomo Tasaka, Kageaki Taima
Publikováno v:
Journal of Thoracic Oncology. 13:S984
Publikováno v:
Journal of Anesthesia. 24:827-831
Patients with cancer suffer a wide range of physical symptoms coupled with psychological stress. Moreover, cancer chemotherapy induces immunosuppression and consequently causes respiratory infections. Massage therapy has been reported to reduce sympt